Page 56 - Read Online
P. 56

Pintos-Morell et al. Rare Dis Orphan Drugs J 2024;3:12  https://dx.doi.org/10.20517/rdodj.2023.52   Page 15 of 15

                   bioinformatics tools and rapid second-tier DNA analyses. Int J Neonatal Screen 2020;6:51.  DOI  PubMed  PMC
               31.      Spiekerkoetter U, Bick D, Scott R, et al. Genomic newborn screening: are we entering a new era of screening? J Inherit Metab Dis
                   2023;46:778-95.  DOI
               32.      Bros-Facer V, Taylor S, Patch C. Next-generation sequencing-based newborn screening initiatives in Europe: an overview. Rare Dis
                   Orphan Drugs J 2023;2:21.  DOI
               33.      Goldenberg AJ, Ponsaran R, Gaviglio A, Simancek D, Tarini BA. Genomics and newborn screening: perspectives of public health
                   programs. Int J Neonatal Screen 2022;8:11.  DOI  PubMed  PMC
               34.      White S, Mossfield T, Fleming J, et al. Expanding the Australian newborn blood spot screening program using genomic sequencing:
                   do we want it and are we ready? Eur J Hum Genet 2023;31:703-11.  DOI  PubMed  PMC
               35.      Smedley D, Smith KR, Martin A, et al. 100,000 genomes pilot on rare-disease diagnosis in health care - preliminary report. N Engl J
                   Med 2021;385:1868-80.  DOI  PubMed  PMC
               36.      Hoytema van Konijnenburg EMM, Wortmann SB, Koelewijn MJ, et al. Treatable inherited metabolic disorders causing intellectual
                   disability: 2021 review and digital app. Orphanet J Rare Dis 2021;16:170.  DOI  PubMed  PMC
               37.      Gold NB, Adelson SM, Shah N, et al. Perspectives of rare disease experts on newborn genome sequencing. JAMA Netw Open
                   2023;6:e2312231.  DOI  PubMed  PMC
               38.      Huang X, Wu D, Zhu L, et al. Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies
                   inborn disorders of neonates. Orphanet J Rare Dis 2022;17:66.  DOI  PubMed  PMC
               39.      Magnifico G, Artuso I, Benvenuti S. A systematic review of real-world applications of genome sequencing for newborn screening.
                   Rare Dis Orphan Drugs J 2023;2:16.  DOI
               40.      Balciuniene J, Liu R, Bean L, et al. At-risk genomic findings for pediatric-onset disorders from genome sequencing vs medically
                   actionable gene panel in proactive screening of newborns and children. JAMA Netw Open 2023;6:e2326445.  DOI  PubMed  PMC
               41.      Bailey DB Jr, Porter KA, Andrews SM, Raspa M, Gwaltney AY, Peay HL. Expert evaluation of strategies to modernize Newborn
                   Screening in the United States. JAMA Netw Open 2021;4:e2140998.  DOI  PubMed  PMC
               42.      Millington DS, Bali DS. Current state of the art of newborn screening for lysosomal storage disorders. Int J Neonatal Screen
                   2018;4:24.  DOI  PubMed  PMC
               43.      Kubaski F, Sousa I, Amorim T, et al. Pilot study of newborn screening for six lysosomal diseases in Brazil. Mol Genet Metab
                   2023;140:107654.  DOI
               44.      Tangeraas T, Constante JR, Backe PH, et al. BCKDK deficiency: a treatable neurodevelopmental disease amenable to newborn
                   screening. Brain 2023;146:3003-13.  DOI
               45.      Plecko B. On pathways and blind alleys-the importance of biomarkers in vitamin B  -dependent epilepsies. J Inherit Metab Dis
                                                                            6
                   2023;46:839-47.  DOI  PubMed
               46.      Abiusi E, Vaisfeld A, Fiori S, et al. Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific
                   guidelines and standard operating procedures for the molecular diagnosis. J Med Genet 2023;60:697-705.  DOI
               47.      Genomics England. Conditions list. List of the genes and conditions that will be included when the Generation Study begins. Available
                   from: https://www.genomicsengland.co.uk/initiatives/newborns/choosing-conditions/conditions-list-generation-study [Last accessed
                   on 23 Apr 2024].
               48.      Liang NSY, Watts-Dickens A, Chitayat D, Babul-Hirji R, Chakraborty P, Hayeems RZ. Parental preferences for expanded newborn
                   screening: what are the limits? Children 2023;10:1362.  DOI  PubMed  PMC
               49.      Rehm HL, Alaimo JT, Aradhya S, et al; Medical Genome Initiative Steering Committee. The landscape of reported VUS in multi-gene
                   panel and genomic testing: time for a change. Genet Med 2023;25:100947.  DOI  PubMed  PMC
               50.      Wu  X,  Yang  Y, Zhou  L,  Long  W,  Yu  B.  Are  we  ready  for  newborn  genetic  screening?  A cross-sectional survey of healthcare
                   professionals in southeast China Front Pediatr 2022;10:875229.  DOI  PubMed PMC
   51   52   53   54   55   56   57   58   59   60   61